 |
|
|
| |
First SVR data with the nucleoside analogue polymerase inhibitor mericitabine (RG7128) combined with peginterferon/ribavirin in
treatment-naive HCV G1/4 patients: interim analysis from the JUMP-C trial
|
| |
| |
Reported by Jules Levin
EASL 2011 Berlin Germany
P. Pockros, D. Jensen, N. Tsai, R.M. Taylor, A. Ramji,
C.L. Cooper, R. Dickson, A. Tice, S. Stancic, D. Ipe,
I. Najera, J.A. Thommes, J.M. Vierling
|
| |
|
|
|
|
|
